Physician profile
Ryan P Murphy
NPI 1023468709
$5,731.41
in general payments reported to CMS, 2019-2025
8 companies · $1,101 in 2025
The $1,101 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2021: $228 · 2022: $350 · 2023: $2,082 · 2024: $1,847 · 2025: $1,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,527 · Food and Beverage: $2,503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,527.08 |
| Food and Beverage | $2,502.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $4,574.61 | 2023-2025 | Indigo System, Smart Coil, Penumbra System |
| Boston Scientific Corporation | $489.98 | 2021-2024 | Embold Fibered, Spyglass |
| Medtronic, INC. | $371.66 | 2022-2025 | Emprint |
| Genentech USA, INC. | $123.57 | 2019 | |
| Stryker Corporation | $63.36 | 2023 | Spinejack |
| Imperative Care, INC | $47.55 | 2024 | Zoom 88-T Large Distal Platform |
| Ethicon US, LLC | $30.36 | 2024 | Certus 140 |
| Depuy Synthes Sales INC. | $30.32 | 2024-2025 | Orthovisc, Monovisc, Trufill |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.